Research programme: MDR-1 cancer vaccine - AC ImmuneAlternative Names: MDR-1 vaccine - AC Immune; MDR1 cancer vaccine - AC Immune
Latest Information Update: 19 Oct 2009
At a glance
- Originator AC Immune
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 11 Jul 2006 Preclinical trials in Cancer in France (unspecified route)